OriGene Technologies, Inc.
Wei-Wu Wei-Wu is currently the CEO at OriGene Technologies, Inc. but they have also held positions at IDG/Accel and Human Genome Sciences. Wei-Wu Wei-Wu has been in the field of science since 1993 where they started as a Scientist at Human Genome Sciences and eventually made their way to their current position.
Wei-Wu Wei-Wu received a BS in biochemistry from Nanjing University, a Ph.D. in molecular biology from Baylor College of Medicine, and an MBA in finance from The Wharton School.
OriGene Technologies, Inc.
OriGene offers over 37,000 human full-length ORF cDNA clones, 50,000 primary antibodies , 10,000 human proteins and other research reagents such as RNAi, assays, tissues, transfection regents for gene based research.